Sage Journals: Discover world-class research

Open access

Case report

First published 2021

Case series: MRD negativity assessment using 11 C-Acetate PET with 3-weekly daratumumab-based quadruplet induction in newly diagnosed multiple myeloma

Cheong Ngai, Shaji Kumar, Garrett Chi-lai Ho [...]

Therapeutic Advances in Hematology

Open access

Research article

First published 2015

Transcriptome Analysis of Minimal Residual Disease in Subtypes of Pediatric B Cell Acute Lymphoblastic Leukemia

Jitsuda Sitthi-Amorn, Betty Herrington, Gail Megason [...]

Clinical Medicine Insights: Oncology

Open access

Research article

First published 2025

The clinical utility and prognostic value of next-generation sequencing for measurable residual disease assessment in acute myeloid leukemia

Yu Liu, Huanchen Cheng, Meng Sun [...]

Therapeutic Advances in Hematology

Open access

Review article

First published 2020

Evaluation and management of measurable residual disease in acute lymphoblastic leukemia

Iman Abou Dalle, Elias Jabbour, Nicholas J. Short

Therapeutic Advances in Hematology

Retricted access

Research article

First published 2016-5

Regulatory Informatics Reveals Minimal Residual Disease Trends in Hematologic Malignancies

Elizabeth A. Rach, Shruti Kalra, Terri Williams [...]

Therapeutic Innovation & Regulatory Science

Open access

Research article

First published 2025

Prognostic significance of MRD and its correlation with arsenic concentration in pediatric acute promyelocytic leukemia: a retrospective study by SCCLG-APL group

Zhong Fan, Liang-Chun Yang, Yi-Qiao Chen [...]

Therapeutic Advances in Hematology

Open access

Research article

First published 2024

Circulating tumor DNA analysis predicts recurrence and avoids unnecessary adjuvant chemotherapy in I–IV colorectal cancer

Wenhua Fan, Zhiyuan Xia, Rongrong Chen [...]

Therapeutic Advances in Medical Oncology

Open access

Research article

First published 2024

Longitudinal genetically detectable minimal residual disease by fluorescence in situ hybridization confers a poor prognosis in myeloma

Jian Cui, Tengteng Yu, Rui Lv [...]

Therapeutic Advances in Medical Oncology

Open access

Review article

First published 2022

Advancing the standard: venetoclax combined with intensive induction and consolidation therapy for acute myeloid leukemia

Curtis A. Lachowiez, Himachandana Atluri, Courtney D. DiNardo

Therapeutic Advances in Hematology

Open access

Research article

First published 2025

Efficacy and safety of anti-CD38 monoclonal antibodies-based therapy versus standard therapy in newly diagnosed multiple myeloma patients: a systematic review and meta-analysis

Muhammad Osama, Muhammad Haris Khan, Safeena Khan [...]

Therapeutic Advances in Hematology

Search results